ArticleFrontiers in oncology2021

CD86 Molecule Might Be a Novel Immune-Related Prognostic Biomarker for Patients With Bladder Cancer by Bioinformatics and Experimental Assays.

Xin Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.